bovin
coronaviru
bcov
bovin
respiratori
syncyti
viru
brsv
contagi
pathogen
detriment
affect
product
anim
welfar
cattl
industri
virus
part
bovin
respiratori
diseas
complex
endem
worldwid
brsv
bcov
caus
epidem
respiratori
diseas
addit
bcov
caus
diarrhea
calv
adult
cattl
winter
dysenteri
tradit
way
handl
prevent
diseas
metaphylact
antibiot
treatment
use
vaccin
chang
manag
improv
calf
health
herd
withinherd
preval
morbid
bcov
brsv
infect
high
viru
enter
herd
circul
difficult
mitig
addit
prevent
strategi
therefor
reduc
interherd
transmiss
viru
movement
live
anim
herd
import
transmiss
rout
risk
control
next
question
concern
contribut
indirect
spread
viru
herd
indirect
spread
occur
via
eg
personnel
travel
herd
cloth
equip
import
risk
factor
indirect
spread
level
viru
contamin
relev
surfac
infect
virus
envelop
respiratori
virus
like
bcov
brsv
gener
fragil
outsid
host
howev
relat
virus
like
human
respiratori
syncyti
viru
hrsv
human
coronaviru
remain
infect
sever
hour
contamin
surfac
like
countertop
surgic
glove
potenti
indirect
transmiss
epidemiolog
studi
also
point
import
indirect
transmiss
ohlson
et
al
found
lack
boot
provis
visitor
risk
factor
infect
virus
toftak
et
al
found
herd
bcov
brsv
antibodi
statu
influenc
statu
neighbor
herd
human
nasal
mucosa
might
also
vector
interherd
viru
transmiss
traffic
personnel
herd
common
carriag
bcov
brsv
human
nostril
studi
gener
studi
indirect
transmiss
virus
experiment
studi
perform
molecular
method
viru
isol
cell
cultur
use
studi
level
viru
carriag
infect
determin
viru
transmiss
combin
method
provid
sensit
quantif
viral
genom
assess
viru
infect
consequ
aim
present
studi
investig
whether
personnel
nostril
fomit
carri
viral
rna
infect
virus
exposur
bcov
brsv
infect
anim
present
studi
perform
two
anim
experi
one
bcov
one
brsv
field
outbreak
winter
dysenteri
swab
rub
nostril
personnel
coat
boot
wristwatch
stethoscop
differ
time
point
anim
contact
examin
viral
rna
infect
virus
bcov
experi
conduct
swedish
univers
agricultur
scienc
slu
describ
oma
et
al
total
ten
bull
calv
six
twelv
week
age
includ
six
swedish
red
white
three
swedish
holstein
one
swedish
mountain
breed
briefli
four
calv
slu
expos
group
six
calv
brought
slu
research
farm
experienc
outbreak
winter
dysenteri
field
outbreak
confirm
rtqpcr
serolog
caus
bcov
comingl
h
calv
hous
isol
unit
within
origin
group
four
six
anim
six
calv
natur
expos
bcov
field
date
infect
unknown
present
contamin
studi
conduct
within
three
week
period
calv
show
sign
diseas
shed
viru
detect
rtqpcr
number
bcov
rna
copi
nasal
swab
ten
calv
vari
mean
studi
period
brsv
experi
took
place
norwegian
veterinari
institut
publish
total
eight
norwegian
red
calv
two
four
month
age
includ
six
bull
two
heifer
briefli
six
calv
infect
contact
two
calv
inocul
field
isol
brsv
calv
hous
isol
unit
group
four
includ
one
inocul
calf
contamin
studi
conduct
three
differ
day
within
one
week
calv
show
sign
respiratori
diseas
shed
viru
number
brsv
rna
copi
nasal
swab
calv
vari
mean
studi
period
experi
conduct
line
arriv
guidelin
plan
report
vivo
experi
concept
reduct
replac
refin
experi
effort
made
minim
stress
discomfort
anim
anim
close
monitor
medic
treatment
administ
line
nation
norwegian
swedish
recommend
treatment
pneumonia
diarrhea
calv
tabl
present
overview
expos
personnel
fomit
ten
minut
personnel
handl
examin
anim
show
clinic
sign
shed
either
bcov
brsv
bcov
experi
swab
collect
human
nostril
prior
h
exposur
anim
brsv
experi
includ
singl
time
point
h
viral
rna
detect
nasal
swab
collect
brsv
pilot
studi
clean
boot
coat
wristwatch
stethoscop
use
exposur
anim
boot
rins
lukewarm
water
visual
clean
left
dri
fomit
store
room
separ
anim
detail
protocol
develop
collect
materi
fomit
human
nostril
person
collect
materi
fomit
experi
instruct
personnel
took
part
human
mucosa
trial
specimen
collect
copan
brescia
itali
store
ml
liquid
ami
medium
glove
use
throughout
experi
specimen
human
nasal
mucosa
collect
rotat
swab
insid
one
nostril
coupl
second
person
sampl
left
right
nostril
sampl
altern
sampl
fomit
perform
moisten
tip
swab
ami
medium
lightli
rub
defin
area
cm
cm
coat
boot
without
visibl
contamin
wristwatch
stethoscop
area
approxim
cm
cm
cm
cm
respect
later
time
point
new
area
sampl
sampl
collect
swab
store
two
hour
thereaft
use
rna
extract
ami
medium
qiaamp
viral
rna
mini
qiacub
kit
qiagen
hilden
germani
accord
manufactur
instruct
elut
buffer
store
rtqpcr
perform
duplic
nasal
swab
use
rna
onestep
quantit
rtpcr
system
invitrogen
usa
target
bp
fragment
protein
gene
two
rna
use
total
volum
ul
contain
nm
forward
revers
primer
nm
taqman
probe
thermal
profil
includ
rt
step
min
follow
min
thereaft
cycl
min
rtqpcr
run
stratagen
agil
technolog
ca
usa
run
includ
posit
rna
nostril
bcov
posit
trial
calf
neg
control
water
posit
swab
human
nasal
mucosa
subject
kaplanmei
surviv
analysi
stata
stata
stata
corp
colleg
station
tx
usa
function
show
cumul
surviv
ie
carriag
bcov
rna
time
descend
personnel
turn
bcov
rna
neg
exact
timepoint
person
turn
neg
unknown
midpoint
last
posit
first
neg
sampl
use
analysi
order
estim
number
bcov
rna
genom
copi
gc
standard
curv
prepar
use
tenfold
dilut
plasmid
contain
bcov
target
sequenc
bcov
rna
posit
control
aliquot
includ
everi
rtqpcr
plate
calibr
adjust
interpl
variat
number
gc
clinic
sampl
calcul
use
formula
livak
schmittgen
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
q
qc
ast
left
left
ct
ct
cright
end
document
qs
sampl
rna
copi
number
qc
calibr
rna
copi
number
ct
sampl
ct
valu
ctc
calibr
ct
valu
e
effici
target
amplif
standard
curv
cover
rang
copi
curv
show
strong
linear
relationship
high
coeffici
determin
high
amplif
effici
e
limit
quantif
repres
bcov
gc
per
swab
human
nasal
mucosa
fomit
rna
extract
ami
medium
use
autom
nuclisen
easymag
protocol
marci
l
etoil
franc
accord
manufactur
instruct
quantif
brsv
genom
conduct
duplic
biorad
ddpcr
system
droplet
digit
pcr
run
includ
posit
rna
nostril
brsv
posit
trial
calf
neg
control
water
droplet
gener
transfer
droplet
describ
manufactur
onestep
rtddpcr
advanc
kit
probe
biorad
ca
usa
rna
use
sequenc
primer
probe
fam
quencher
describ
target
bp
region
brsv
n
gene
primer
probe
concentr
recommend
kit
manufactur
follow
cycl
condit
min
min
cycl
min
ramp
rate
set
data
process
absolut
quantif
brsv
genom
per
rna
perform
quantasoft
version
biorad
halflif
calcul
brsv
rna
carriag
unattain
due
singl
sampl
viru
infect
test
five
sampl
highest
level
bcov
rna
use
integr
cell
cultur
rtqpcr
swab
wristwatch
stethoscop
coat
collect
h
exposur
two
human
nostril
collect
min
exposur
swab
medium
dilut
dulbecco
modifi
eagl
medium
dmem
thermo
fisher
scientif
de
usa
ad
duplic
well
monolay
human
rectal
tumor
cell
atcc
plate
posit
control
cultiv
bcov
calf
experi
posit
control
ami
medium
neg
control
cell
includ
incub
one
hour
inoculum
remov
cell
wash
dmem
fetal
calf
serum
fc
antibiot
iu
penicillin
mg
streptomycinml
ad
simultan
cell
harvest
one
parallel
well
sampl
time
zero
replic
control
three
day
incub
cell
harvest
remain
well
rna
extract
qiazol
qiagen
chloroform
phase
separ
mix
ethanol
rneasi
mini
kit
column
qiagen
amount
rna
measur
use
nanodrop
thermo
fisher
scientif
equal
amount
analyz
bcov
rtqpcr
run
duplic
describ
rel
quantif
target
rna
incub
time
zero
replic
control
cell
perform
use
standard
curv
brsv
infect
test
ten
swab
show
highest
level
viral
rna
rtddpcr
eight
swab
coat
two
human
nostril
collect
h
min
exposur
respect
fetal
bovin
turbin
cell
courtesi
swedish
veterinari
institut
propag
eagl
minim
essenti
medium
biowhittak
belgium
well
plate
incub
filter
swab
sampl
min
medium
fc
ad
plate
incub
supernat
passag
seven
day
sampl
cultiv
duplic
posit
cultiv
brsv
calf
experi
neg
control
cell
cell
observ
cytopath
effect
cpe
infect
visual
direct
immunofluoresc
test
use
fitc
moab
abrsv
biox
diagnost
rochefort
belgium
cultur
supernat
harvest
test
brsv
rtddpcr
describ
posit
control
consist
posit
throughout
analys
neg
control
neg
viral
rna
detect
human
nasal
mucosa
sampl
prior
exposur
anim
howev
posit
found
among
sampl
collect
exposur
tabl
number
bcov
gc
per
swab
shown
fig
estim
halflif
bcov
rna
carriag
less
min
estim
longest
persist
five
hour
fig
posit
brsv
swab
contain
genom
copi
posit
control
consist
posit
throughout
analys
neg
control
neg
bcov
rna
detect
boot
coat
stethoscop
seven
eight
wristwatch
h
exposur
eighth
watch
posit
bcov
rna
min
two
hour
exposur
copi
number
bcov
rna
h
exposur
present
fig
brsv
rna
detect
boot
sampl
two
hour
boot
h
coat
posit
two
hour
exposur
posit
h
minor
differ
brsv
rna
copi
number
sampl
collect
h
exposur
tendenc
reduct
copi
number
fig
rtqpcr
result
cell
inocul
swab
materi
wristwatch
stethoscop
indic
increas
number
rnacopi
three
day
incub
cell
inocul
swab
materi
human
nostril
rubber
coat
show
increas
viral
rna
incub
posit
viru
control
posit
ami
medium
show
inhibit
viru
replic
bcov
rna
detect
neg
control
well
cpe
seen
cell
incub
swab
materi
passag
materi
rtddpcr
result
indic
viru
replic
two
passag
cell
posit
control
well
posit
neg
control
well
neg
first
time
bcov
brsv
contamin
personnel
fomit
describ
pcr
result
indic
fomit
like
cloth
boot
wristwatch
stethoscop
expos
viru
pose
infect
risk
cattl
bcov
particular
fomit
seem
repres
high
risk
viru
isol
detect
infect
virus
h
consequ
measur
prevent
interherd
transmiss
includ
action
indirect
spread
viru
high
copi
number
viral
rna
fomit
indic
transmiss
potenti
investig
perform
order
assess
whether
detect
rna
could
repres
infect
virus
although
infect
ideal
studi
live
anim
cell
cultur
use
due
practic
ethic
econom
reason
viru
isol
cell
cultur
may
low
sensit
use
integr
cell
cultur
rtqpcr
increas
possibl
detect
infect
virus
use
method
show
visual
clean
surfac
fomit
carri
infect
bcov
least
h
exposur
infect
anim
review
la
rosa
et
al
relat
coronavirus
hrsv
transmit
fomit
addit
direct
transmiss
droplet
aerosol
therefor
plausibl
bcov
brsv
could
transmit
farm
via
personnel
fomit
even
protect
cloth
use
chang
herd
personnel
might
constitut
risk
viru
transmiss
human
nasal
mucosa
could
potenti
hideaway
infect
virus
addit
bcov
isol
diarrheic
child
like
ancestor
relat
human
pathogen
thu
abil
replic
cell
human
nasal
mucosa
exclud
human
nasal
mucosa
therefor
studi
place
skin
oral
mucosa
hair
could
also
act
passiv
vector
virus
seller
et
al
shown
human
nasal
mucosa
possibl
vehicl
footandmouthdiseas
viru
even
high
level
biosecur
implement
refut
amass
et
al
found
low
risk
viru
transmiss
personnel
hand
wash
chang
outerwear
wright
et
al
found
low
risk
prolong
human
nasal
carriag
viru
present
studi
aim
studi
whether
human
nasal
mucosa
possibl
vehicl
transmiss
bcov
brsv
base
result
possibl
low
level
viral
rna
failur
detect
infect
viru
hour
indic
low
risk
viru
transmiss
human
nasal
mucosa
present
studi
personnel
sampl
experiment
set
outbreak
winter
dysenteri
field
result
show
nasal
carriag
bcov
human
less
common
outbreak
situat
anim
experi
factor
could
influenc
amount
viru
two
set
differ
viru
exposur
degre
contact
anim
personnel
environment
condit
factor
could
repeat
swab
nostril
nose
touch
nose
blow
find
neither
bcov
brsv
could
cultiv
human
nasal
swab
resembl
rapid
inactiv
skin
respiratori
syncyti
viru
human
coronaviru
could
due
substanc
microorgan
mucosa
neutral
inactiv
viru
although
chanc
underestim
risk
due
eg
freez
thaw
dilut
filter
sampl
viru
transmiss
potenti
mucosa
probabl
low
sign
bcov
replic
human
nasal
mucosa
amount
bcov
rna
found
low
declin
time
despit
gener
view
envelop
virus
fragil
outsid
host
sever
coronavirus
remain
infect
dri
surfac
h
review
otter
et
al
present
studi
indic
bcov
similar
properti
infect
brsv
hand
detect
sampl
similar
hrsv
dri
surfac
seven
hour
studi
hrsv
surviv
cell
cultur
medium
aerosol
also
show
higher
inactiv
rate
compar
coronavirus
suggest
brsv
suscept
bcov
degrad
environment
factor
import
indirect
brsv
transmiss
h
probabl
low
demonstr
mulli
et
al
viral
infect
rapidli
lost
viral
rna
virus
viral
rna
level
recov
boot
lower
coat
possibl
due
rins
water
howev
high
genom
copi
number
remain
rins
might
suffici
prevent
viru
transmiss
support
epidemiolog
data
show
increas
risk
seroposit
brsv
bcov
herd
provid
boot
visitor
present
bcov
experi
indic
also
stethoscop
wristwatch
could
serv
vehicl
item
often
brought
farm
without
cleaningdisinfect
carri
infect
viru
particl
least
h
exposur
infect
cattl
personnel
pose
risk
interherd
transmiss
brsv
bcov
bring
fomit
herd
order
control
spread
virus
biosecur
measur
implement
includ
herdspecif
cloth
equip
washingdisinfect
fomit
although
personnel
may
carri
virus
intranas
shorter
period
time
rel
import
contamin
mucosa
indirect
transmiss
less
contamin
fomit
